Paxil CR Bioequivalence Study Brazil

Clinical trial NCT01316926 · COMPLETED

Trial details

NCT number: NCT01316926
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Depressive Disorder

Start date: 2009-09-09
Primary completion: 2009-10-05
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.